Activin receptor ligand traps in chronic kidney disease
Sign Up to like & getrecommendations! Published in 2018 at "Current Opinion in Nephrology and Hypertension"
DOI: 10.1097/mnh.0000000000000433
Abstract: Purpose of review Sotatercept and luspatercept are recombinant soluble activin type-II receptor-IgG-Fc fusion proteins that are tested in clinical trials for the treatment of various types of anemias, including renal anemia. The mechanism of the… read more here.
Keywords: activin; chronic kidney; receptor; ligand traps ... See more keywords